2022 annual financial data
Amylyx Pharmaceuticals 2022 Operating margin
Amylyx Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was -905.72%.
Operating income was -201,341,000 USD and net income was -198,375,000 USD.
Operating cash flow was -179,871,000 USD.
Get free Amylyx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 22,230,000 USD
- Operating income
- -201,341,000 USD
- Net income
- -198,375,000 USD
- Operating cash flow
- -179,871,000 USD